癌症
癌症研究
医学
血管内皮生长因子受体
转移
淋巴结转移
肿瘤科
淋巴结
信号转导
内科学
生物
细胞生物学
作者
Kenji Shimizu,Hajime Kubo,Koji Yamaguchi,Kazuhiko Kawashima,Yoshihide Ueda,Koichi Matsuo,Masaaki Awane,Yasuyuki Shimahara,Arimichi Takabayashi,Yoshio Yamaoka,Seiji Satoh
出处
期刊:Cancer Science
[Wiley]
日期:2004-04-01
卷期号:95 (4): 328-333
被引量:151
标识
DOI:10.1111/j.1349-7006.2004.tb03211.x
摘要
In gastric cancer, lymph node metastasis is one of the major prognostic factors and forms the basis for surgical removal of local lymph nodes. Recently, several studies have demonstrated that overexpression of lymphangiogenic growth factor VEGF-C or VEGF-D induces tumor lymphangiogenesis and promotes lymphatic metastasis in mouse tumor models. We examined whether these processes could be inhibited in naturally metastatic tumors by blocking of their cognate receptor VEGFR-3 signaling pathway. Using a mouse orthotopic gastric cancer model which has a high frequency of lymph node metastasis, we estimated lymphatic vessels in gastric cancers by immunostaining for VEGFR-3 and other specific lymphatic markers, LYVE-1 and prox-1. Then we systemically administered anti-VEGFR-3 blocking antibodies. This treatment resulted in the inhibition of regional lymph node metastasis and reduction of lymphatic vessel density in the primary tumors. In addition, increased density of LYVE-1-positive lymphatic vessels of primary tumors was closely correlated with lymph node metastasis in human samples of gastric cancer. Antilymphangiogenesis by inhibiting VEGFR-3 signaling could provide a potential strategy for the prevention of lymph node metastasis in gastric cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI